A Day in the Life: Improving Collaboration to Minimize Exposure to Hazardous Drugs from Preparation to Administration and Beyond
| ACPE Activity Number: 0204-0000-22-416-H01-P Release Date: 11/14/2022 Expiration Date: 11/14/2023 Activity Type: Application-based CE Credits: 1 contact hour (.01 CEUs) CNE Credits: 1 contact hour Activity Fee: Free of charge |
 |
This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.
Activity Overview
The safety mechanisms involved with preparation and administration of hazardous drugs (HDs) are put in place to protect all healthcare workers. Healthcare workers must have an understanding of the potential for exposure to HDs and how that exposure could impact their health. Pharmacists who prepare HDs are accustomed to following safety guidelines and recommendations for safe handling, but there is room for improvement when it comes to educating and collaborating with others who may come in contact with these products after they leave the pharmacy, especially nurses. This educational activity will increase awareness of the various means of exposure to HDs that can occur in the health system. Standard operating procedures that have been shown to minimize workplace contamination and exposure to HDs during preparation and administration will be reviewed (e.g., CSTD technologies and safety features).
|
|
 |
|
On-Demand Activity* A Day in the Life: Improving Collaboration to Minimize Exposure to Hazardous Drugs from Preparation to Administration and Beyond |
Engaging the Experts Podcasts Podcast 1: Turn the Page for New Perspectives on USP Chapter 800 Podcast 2: Title TBD |
| CE Credits: 1.00 hours |
CE Credits: none |
*Please note, this activity was presented live on 10/13/2022 - you can only claim credit once for this activity; live or home study
Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.This nursing continuing professional development activity was approved by Maryland Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
Target Audience
This activity was planned to meet the educational needs of pharmacists and nurses who prepare, administer, or otherwise handle hazardous medications in the course of their work.
Learning Objectives
At the conclusion of this activity, participants should be able to:
• Review various methods of exposure to hazardous drugs that healthcare workers may encounter in the workplace.
• Identify strategies for improving pharmacist/nurse collaboration in the safe handling, preparation and administration of hazardous drugs.
• Discuss standard operating procedures that minimize workplace contamination and exposure to hazardous drugs during preparation and administration (e.g., CSTD technologies and safety features).
Faculty
Stephen Eckel, PharmD, MHA, FASHP
Associate Dean for Global Engagement
Associate Professor
Director of Pharmacy, Innovation Services
UNC Medical Center
Chapel Hill, North Carolina
Stephen Eckel, Pharm.D., MHA, BCPS, is Associate Director of Pharmacy and Director, Pharmacy Residency Programs at UNC Hospitals in Chapel Hill, North Carolina. Dr. Eckel is also Clinical Associate Professor and Vice Chair, Graduate and Post-Graduate Education in the division of practice advancement and clinical education at the University of North Carolina Eshelman School of Pharmacy.
Dr. Eckel is known as an innovator and entrepreneur within the pharmacy profession. He conducts and publishes research related to safe handling of hazardous drugs among other topics and is frequently asked to speak around the world on these issues.
AnnMarie Lee Walton, PhD, MPH, RN, OCN, CHES, FAAN
Assistant Professor
Duke University School of Nursing
Durham, North Carolina
AnnMarie Lee Walton, PhD, MPH, RN, OCN, CHES, FAAN Dr. AnnMarie Walton is an Assistant Professor at the Duke University School of Nursing. She conducts research to understand and minimize antineoplastic drug exposure for healthcare workers. Dr. Walton has promoted legislative efforts to mandate safer handling of hazardous drugs and received the 2016 Oncology Nursing Society (ONS) Excellence in Health Policy and Advocacy Award. She is a content expert on safe handling projects and co-led the ONS/Hematology/Oncology Pharmacist Association (HOPA) joint position statement on safe handling of hazardous drugs and is the co-editor of the forthcoming ONS Safe Handling Text.
Relevant Financial Relationship Disclosures
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
Methods and CE Requirements
Activities can be completed in any order. Learners must review all content and complete an evaluation to receive continuing education credit for each activity that offers CE.
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
Important Note – ACPE 60 Day Deadline
Provided by ASHP.
Supported by an educational grant from Equashield, LLC.